External Defibrillator Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global External Defibrillator Market Trends and Insights

Rising Burden of Sudden Cardiac Arrests Globally

Out-of-hospital cardiac arrest affects more than 350,000 people each year in the United States, yet survival-to-discharge remains below 12%, intensifying the need for rapid defibrillation. Aging populations and a higher prevalence of metabolic syndrome are amplifying case volumes across Europe and the Asia-Pacific region, thereby broadening the external defibrillator market. Every minute of defibrillation delay reduces the survival probability by 7% to 10%, prompting health authorities to prioritize the placement of devices in public venues. The 2025 American Heart Association guidelines extended perioperative defibrillation recommendations, prompting the procurement of defibrillators into surgical suites^{[1]American Heart Association, “2025 Guidelines Update,” heart.org}. While epidemiological pressure is high, closing the survival gap also requires training initiatives, compelling manufacturers to bundle education with device sales.

Expanding Public-Access Defibrillation Programs and Mandates

State rules such as Maine’s health club AED requirement and New Jersey’s school deployment law have accelerated institutional purchases in the United States. In December 2025, PulsePoint and ZOLL Medical launched the National Emergency AED Registry to provide dispatch centers with real-time device location data, thereby shortening response times[2]. Europe’s 2022 peri-operative guidelines are driving National Health Service trusts to standardize equipment stocks, and China’s December 2024 policy reforms cut clinical review timelines to 30 days in pilot zones. Compliance remains uneven because few jurisdictions enforce penalties; however, the direction is firmly toward broader deployment, which supports demand growth in the external defibrillator market.

Technological Advancements in Smart and Connected AEDs

AliveCor received U.S. FDA clearance in June 2024 for a portable 12-lead AI-powered electrocardiogram, demonstrating that hospital-grade diagnostics can be integrated into field devices[3]. Stryker’s LIFEPAK 35 offers cloud dashboards that alert fleet managers when batteries or electrodes are nearing expiration, thereby reducing downtime and maintenance costs. Peer-reviewed studies in 2024 demonstrated that on-device deep-learning algorithms can effectively guide chest compressions, achieving area-under-the-curve scores above 0.90, thereby enhancing lay-rescuer performance. These capabilities differentiate premium products and open recurring-revenue models, elevating the strategic importance of software engineering resources within defibrillator firms.

Growing Adoption of Wearable Cardioverter Defibrillators

Wearable cardioverter defibrillators, such as ZOLL’s LifeVest, serve high-risk patients during the vulnerable post-discharge window, and expanded Medicare coverage after 2024 will reduce out-of-pocket costs. Clinical trials have documented the effectiveness of arrhythmia detection; however, adherence averages roughly 70% due to garment discomfort, which limits the absolute volumes. Companies are investing in lighter fabrics and wireless electrode arrays; however, the trade-off between continuous monitoring and patient convenience remains. Cardiologists increasingly favor hybrid platforms that combine wearables with cloud analytics, supporting individualized therapy titration and strengthening the external defibrillator industry’s service revenues.

High Total Cost of Ownership and Maintenance

The retail price of an automated external defibrillator averages USD 2,338, but batteries and electrode pads require replacement every 2 to 5 years, pushing lifetime outlays above USD 4,000. Schools and community centers with limited budgets often defer the acquisition of refurbished units that lack software updates, creating a bifurcated installed base. Field audits in 2024 revealed 18% of public devices had expired electrodes and 12% had depleted batteries, undermining emergency readiness. The 2026 Durable Medical Equipment fee schedule raised allowable charges by only 2%, leaving most public-access deployments unfunded. Subscription models that bundle hardware, consumables, and monitoring are emerging to convert capital expenditure into predictable operating expenses.

Insufficient Public Awareness and Training

Bystander AED activation remains below 40% worldwide, reflecting limited knowledge about device locations and Good Samaritan legal protections. Only one-fifth of U.S. adults held a current CPR/AED certification in 2025, which limits the public health impact of the external defibrillator market. Virtual-reality training platforms can scale education, but their adoption tends to skew toward corporations rather than community programs. Regulators do not mandate end-user training, so manufacturers bear the burden of awareness campaigns, which erode their margins. To address underutilization, leading vendors partner with fire departments and emergency medical service agencies to embed device familiarization into CPR curricula, aligning commercial goals with public safety missions.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product: Manual Devices Anchor Revenue, AEDs Propel Volume Growth

Manual external defibrillators captured 45.43% of the external defibrillator market share in 2025, reinforcing their role in critical-care environments that require invasive pressure monitoring and capnography. Average selling prices range between USD 15,000 and USD 25,000, and multi-parameter integrations justify hospital budget allocations despite lengthier replacement cycles. Automated external defibrillators, priced one-tenth as much, are set to expand at 9.54% CAGR, making them the key driver of unit shipments in the external defibrillator market. The external defibrillator market size for automated models is projected to increase by USD 1.25 billion between 2026 and 2031 as public venues update their fleets to comply with new registry-tracking standards. Wearable cardioverter defibrillators remain a niche, but robust clinical evidence and broader reimbursement could unlock incremental growth.

Feature roadmaps emphasize connectivity—Stryker’s LIFEPAK 35 uploads readiness data to cloud portals, allowing biomedical engineers to schedule maintenance proactively. AliveCor’s 12-lead device blurs lines between responder tools and diagnostic equipment, challenging incumbents to integrate high-resolution sensing without compromising lay-user simplicity. Manual defibrillator suppliers face price pressure as group purchasing organizations negotiate bulk contracts; however, premium software modules for post-event data analytics and protocol compliance help protect margins.

By Patient Type: Adults Dominate, Pediatrics Accelerates

Adults generated 64.56% of the revenue in 2025, reflecting the higher incidence of cardiac arrest in populations older than 50 years and well-established energy-dose protocols. The external defibrillator market size for adult indications is projected to reach USD 4.05 billion by 2031, as lifestyle-related cardiovascular risks continue to rise. Pediatric demand is advancing at a 9.66% CAGR, driven by state laws that require school campuses and youth sports facilities to stock child-capable AEDs. Pediatric-specific electrodes deliver 50-75 joules, minimizing myocardial injury while preserving shock efficacy. Dedicated pediatric units simplify operation but raise inventory costs because institutions must maintain separate fleets, prompting many buyers to favor dual-mode devices with switchable pads.

Regulators now require age-stratified clinical data for marketing claims, which extends development timelines but improves safety profiles. Manufacturers are introducing color-coded prompts and child-size illustrations to minimize cognitive load during high-stress scenarios. Continued guideline updates are likely to expand indications to neonatal resuscitation in surgical suites, creating additional, albeit small, revenue pockets within the external defibrillator industry.

By End-User: Institutional Core Faces Home-Care Disruption

Hospitals and cardiac centers accounted for 54.56% of revenue in 2025, valuing advanced monitoring that allows seamless integration with electronic medical records. However, payer pressure to prevent readmissions is steering providers toward remote monitoring platforms, which are migrating some therapies into the community. The external defibrillator market size in home-health settings is projected to increase from USD 0.28 billion in 2026 to USD 0.46 billion by 2031, driven by the adoption of wearable cardioverter defibrillators and tele-cardiology dashboards. Public-access locations continue to expand unit counts as liability insurers mandate on-site devices; nonetheless, field inspections reveal maintenance gaps that reduce functional availability during critical moments.

Emergency medical services rely on ruggedized devices capable of delivering shocks en route to hospitals, and many deploy automatic chest-compression adjuncts to maintain circulation. Subscription models that cover devices, batteries, pads, and cloud analytics are gaining popularity among schools and small businesses because they eliminate the need for large upfront purchases. Partnerships, such as the PulsePoint-ZOLL registry, reinforce ecosystem advantages by linking hardware fleets to public-safety workflows, thereby enhancing stickiness and driving recurring revenue.

Geography Analysis

Asia-Pacific is projected to be the fastest-growing region in the external defibrillator market, expanding at an 8.54% CAGR through 2031. China’s December 2024 regulatory reforms halved clinical-trial review timelines in pilot zones, accelerating approvals for automated models and encouraging local manufacturing. India’s Production Linked Incentive scheme selected BPL Medical Technologies and Allied Medical Limited for domestic production grants, reducing import reliance and improving price competitiveness. Japan’s super-aged demographics support institutional procurement, but cultural hesitation toward bystander intervention tempers public-access utilization rates. Localized production, exemplified by BIOTRONIK’s Singapore hub, shortens supply chains and sidesteps tariff volatility, positioning multinationals to respond swiftly to regional demand spikes.

North America exhibits mature deployment densities, with most public venues already equipped; growth, therefore, stems from technology refreshes and software upgrades. State mandates, such as Maine’s health-club rule, still generate incremental unit sales, but replacement cycles now stretch beyond seven years as hardware reliability improves. Europe is undergoing a supply-chain restructuring following the June 2025 International Procurement Instrument's restriction on Chinese devices in large public tenders, prompting hospitals to shift their orders to regional manufacturers. The change opens up opportunities for European mid-caps, but also presents component-sourcing challenges, as many sub-assemblies originate in China.

The Middle East and Africa remain nascent yet promising segments. Gulf Cooperation Council states are investing in national ambulance modernization, importing defibrillators with Arabic-language interfaces, whereas sub-Saharan markets rely on donor-funded public health projects. South America is expanding slowly; Brazil’s public-access initiative in São Paulo mandates AEDs in transport terminals, but high import tariffs hinder volume growth. Overall, geographic diversification necessitates multiple regulatory pathways, compelling manufacturers to tailor product documentation, language packs, and post-market surveillance procedures for each jurisdiction.

Regulatory Landscape

Regulation for external defibrillators continues to be shaped by high-risk device classifications and tighter requirements for connected features. In the United States, automated external defibrillators (AEDs) are regulated by the FDA as Class III devices and generally require Premarket Approval (PMA), with FDA oversight extending to system accessories such as batteries and pad electrodes. This structure tends to favor suppliers with established quality systems and long-lived component supply.

In the European Union, market access is governed by Regulation (EU) 2017/745 (MDR), where defibrillators face stringent conformity assessment and post-market surveillance expectations. Compliance across regions increasingly depends on adherence to evolving technical and labeling standards, with cardiac defibrillator safety and essential performance mapped to IEC 60601-2-4 and European adaptations (including EN 60601-2-4:2011/prA2 updates). In 2026, the European Commission continued MDR implementation through updates to harmonized standards lists in the Official Journal and issued additional implementing measures affecting conformity assessment and notified bodies, keeping regulatory readiness and standards management central to product lifecycle planning.

Market Opportunities and Future Outlook

Connected, remotely managed AED fleets remain a clear whitespace in public-access settings where maintenance gaps persist and device readiness can only be checked intermittently. This supports opportunities for vendors that combine hardware with fleet-management software and align with local response workflows, building on market moves such as the December 2025 PulsePoint and ZOLL Medical National Emergency AED Registry that enables real-time device location visibility for dispatch. The same direction is visible in vendor roadmaps: in July 2026, CU Medical Systems disclosed plans to integrate its RMS LINK remote management system with location-based mobility applications to improve AED accessibility and emergency infrastructure in living zones.

Regulatory progress for new connected AED platforms also supports product refresh and differentiation anchored in compliance and cybersecurity. In May 2026, the FDA accepted the PMA application for HeartHero's connected AED (Elliot), indicating continued investment in Class III-grade connected devices and giving competitors a basis to position upgraded connectivity, analytics, and remote monitoring features. Separately, portfolio carve-outs create an additional execution lane: Emergency Care Holdings completed the acquisition of Philips Emergency Care in January 2026 and operates the business as Heartstream under a brand license, leaving room for accelerated platform modernization, channel re-organization, and refreshed public-access offerings based on the legacy HeartStart installed base.